StockVS

NASDAQ · USD

Medicus Pharma Ltd. (MDCXW) Stock Analysis

Medicus Pharma Ltd. (MDCXW) is a stock listed on NASDAQ and quoted in US Dollar.

MDCXW

$0.31

−$0.02 (−6.03%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on Medicus Pharma Ltd. (MDCX) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View MDCX →

Price History

Hover for the daily close. The dotted line marks the period open.

MDCXW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.99
Previous Close
$0.33
52-Week Range
0.31–2.50
Volume
228
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.48

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MDCXW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−87.60%
2025 (partial year)+0.00%

As of September 4, 2026.

About Medicus Pharma Ltd.

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Visit website →